Hypoxanthine in cerebrospinal fluid in children

Area of Science:

• Biochemistry
• Pediatrics
• Neurology

Background:

• Hypoxanthine is a purine derivative that can indicate cellular metabolism and oxygenation status.
• Cerebrospinal fluid (CSF) analysis offers insights into the central nervous system's metabolic state.

Purpose of the Study:

• To investigate hypoxanthine concentrations in the CSF of pediatric patients.
• To determine the correlation between CSF hypoxanthine levels and hypoxic conditions in neonates and children with various diseases.

Main Methods:

• CSF samples were collected from 45 children (52 samples).
• Hypoxanthine concentrations were measured in all samples.
• Levels were compared between neonates with and without clinical hypoxia.
• CSF hypoxanthine was analyzed in children with conditions like meningitis, febrile convulsions, and lymphoblastic leukemia.

Main Results:

• Neonatal patients with clinical hypoxia (respiratory distress syndrome, asphyxia, apneic attacks) showed significantly higher CSF hypoxanthine levels compared to non-hypoxic neonates (P < 0.01).
• In hypoxic neonates, hypoxanthine levels ranged from 5 to 28 μmol/l.
• In non-neonatal children, CSF hypoxanthine concentrations varied significantly across different diseases.
• Elevated CSF hypoxanthine was noted in pre-treatment meningitis, febrile convulsions, and lymphoblastic leukemia.

Conclusions:

• Elevated CSF hypoxanthine levels in neonates are indicative of hypoxic conditions.
• Increased CSF hypoxanthine in older children may reflect tissue hypoxia and heightened catabolism in diseases such as meningitis, febrile convulsions, and leukemia.
• CSF hypoxanthine measurement could serve as a biomarker for hypoxia and altered metabolism in pediatric neurological conditions.